RE: A Cost-Effectiveness Modeling Evaluation Comparing a Biosimilar Follitropin Alfa Preparation With Its Reference Product for Live Birth Outcome in Germany, Italy and Spain
Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2019.1576181
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 11, 2019
Authors
Publisher
Informa UK Limited